Rethinking Oral Corticosteroid Therapy for Myasthenia Gravis
Episode Summary
Oral corticosteroids remain central in myasthenia gravis, but clinicians are shifting toward individualized dosing, combination therapies, and safer long-term strategies to reduce treatment burden and complications.